Ms See is an early-stage investor and company builder, specialising in transforming raw scientific and engineering research into commercially viable ventures. She was the founding CEO of Xora Innovation, a wholly owned subsidiary of Temasek Holdings, investing globally across human health, climate and sustainability, and advanced computing. Previously, she served in founding executive roles, as Chief Business Officer of TARA Biosystems (acquired), accelerating the development of precision cardio-medicines, as a co-founder of Vixen Pharmaceuticals (acquired), a company dedicated to therapies for autoimmune dermatologic conditions, and as Chief Business Officer of Allied- Bristol Life Sciences, a joint venture between Allied Minds and Bristol-Myers Squibb, developing therapeutic assets from leading U.S. academic labs. Ms See has extensive experience as an independent and investor director of early-stage companies in Singapore and the U.S. and as an advisor to numerous scientific translation and incubation programs in both geographies. Ms See received her MBA and MPH (Master of Public Health) from Columbia University and holds a BA in the Natural Sciences from The Johns Hopkins University.